{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:40:48Z","timestamp":1765806048444},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>This report describes a 49-year-old male construction worker who acquired a Bacillus anthracis infection after working on a sheep farm. He experienced a severe respiratory infection, septic shock, and hemorrhagic meningoencephalitis with severe intracranial hypertension. After several weeks with multiple organ dysfunction syndrome, he responded favorably to antibiotic treatment. Three weeks into his hospitalization, an intracranial hemorrhage and cerebral edema led to an abrupt deterioration in his neurological status. A single dose of raxibacumab was added to his antimicrobial regimen on hospital day 27. His overall status, both clinical and radiographic, improved within a few days. He was discharged 2 months after admission and appears to have fully recovered.<\/jats:p>","DOI":"10.1093\/cid\/ciac531","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T16:42:06Z","timestamp":1661359326000},"page":"S364-S372","source":"Crossref","is-referenced-by-count":8,"title":["Survival of Patient With Hemorrhagic Meningitis Associated With Inhalation Anthrax"],"prefix":"10.1093","volume":"75","author":[{"given":"Evelyn","family":"Lombarte Espinosa","sequence":"first","affiliation":[{"name":"Servicio Medicina Intensiva, UCI Polivalente, Hospital Universitario Miguel Servet , Zaragoza , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Cruz","family":"Villuendas Us\u00f3n","sequence":"additional","affiliation":[{"name":"Servicio Microbiolog\u00eda, Hospital Universitario Miguel Servet, IIS Arag\u00f3n , Zaragoza , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Arribas Garc\u00eda","sequence":"additional","affiliation":[{"name":"Servicio Microbiolog\u00eda, Hospital Comarcal Alca\u00f1iz , Teruel , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Jado Garc\u00eda","sequence":"additional","affiliation":[{"name":"Laboratorio de Referencia e Investigaci\u00f3n en Pat\u00f3genos Especiales, Centro Nacional de Microbiolog\u00eda. Instituto de Salud Carlos III , Madrid , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Huarte Lacunza","sequence":"additional","affiliation":[{"name":"Servicio de Farmacia Hospitalaria, Hospital Universitario Miguel Servet , Zaragoza , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Z\u00e1rate Chug","sequence":"additional","affiliation":[{"name":"Servicio Medicina Intensiva, UCI Polivalente, Hospital Universitario Miguel Servet , Zaragoza , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Manuel","family":"Claraco Vega","sequence":"additional","affiliation":[{"name":"Servicio Medicina Intensiva, UCI Polivalente, Hospital Universitario Miguel Servet , Zaragoza , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Jes\u00fas Santed Andr\u00e9s","sequence":"additional","affiliation":[{"name":"Servicio Medicina Intensiva, UCI Polivalente, Hospital Universitario Miguel Servet , Zaragoza , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jim\u00e9nez","family":"R\u00edos","sequence":"additional","affiliation":[{"name":"Servicio Medicina Intensiva, UCI Polivalente, Hospital Universitario Miguel Servet , Zaragoza , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Cook","sequence":"additional","affiliation":[{"name":"Oak Ridge Institute for Science and Education, CDC Fellowship Program, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J Marc","family":"Simard","sequence":"additional","affiliation":[{"name":"Departments of Neurosurgery, Pathology and Physiology, University of Maryland School of Medicine , Baltimore, Maryland , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne E","family":"Boyer","sequence":"additional","affiliation":[{"name":"Division of Laboratory Sciences, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rezusta","sequence":"additional","affiliation":[{"name":"Servicio Microbiolog\u00eda, Hospital Universitario Miguel Servet, IIS Arag\u00f3n , Zaragoza , Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"key":"2022101808245898900_ciac531-B1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","article-title":"Anthrax toxin","volume":"19","author":"Collier","year":"2003","journal-title":"Annu Rev Cell Dev Biol"},{"key":"2022101808245898900_ciac531-B2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-micro-091014-104523","article-title":"Anthrax pathogenesis","volume":"69","author":"Moayeri","year":"2015","journal-title":"Annu Rev Microbiol"},{"key":"2022101808245898900_ciac531-B3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0966-842X(02)02422-8","article-title":"The alveolar macrophage: the trojan horse of Bacillus anthracis","volume":"10","author":"Guidi-Rontani","year":"2002","journal-title":"Trends Microbiol"},{"key":"2022101808245898900_ciac531-B4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1017\/S0022172400044272","article-title":"Observations on the prophylaxis of experimental pulmonary anthrax in the monkey","volume":"54","author":"Henderson","year":"1956","journal-title":"J Hyg (Lond)"},{"key":"2022101808245898900_ciac531-B5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/ajcp\/17.9.719","article-title":"Anthrax meningitis; report of a case of internal anthrax with recovery","volume":"17","author":"Shanahan","year":"1947","journal-title":"Am J Clin Pathol"},{"key":"2022101808245898900_ciac531-B6","first-page":"533","article-title":"The treatment of human anthrax with penicillin","volume":"2","author":"Weinstein","year":"1948","journal-title":"Am Pract Dig Treat"},{"key":"2022101808245898900_ciac531-B7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1542\/peds.50.2.329","article-title":"Survival in anthrax meningitis","volume":"50","author":"Tahernia","year":"1972","journal-title":"Pediatrics"},{"key":"2022101808245898900_ciac531-B8","first-page":"337","article-title":"Anthrax meningitis: report of two cases","volume":"50","author":"Tengio","year":"1973","journal-title":"East Afr Med J"},{"key":"2022101808245898900_ciac531-B9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0002-9343(77)90358-8","article-title":"Survival of a patient with intestinal anthrax","volume":"62","author":"Nalin","year":"1977","journal-title":"Am J Med"},{"key":"2022101808245898900_ciac531-B10","first-page":"315","article-title":"Successfully treated primary anthrax meningitis","volume":"32","author":"Khanna","year":"1989","journal-title":"Indian J Pathol Microbiol"},{"key":"2022101808245898900_ciac531-B11","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/00006454-199312000-00020","article-title":"Bacillus anthracis as a cause of bacterial meningitis","volume":"12","author":"Tabatabaie","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"2022101808245898900_ciac531-B12","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"2022101808245898900_ciac531-B13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/09546630305547","article-title":"Cutaneous anthrax associated with facial palsy: case report and literature review","volume":"14","author":"Faghihi","year":"2003","journal-title":"J Dermatolog Treat"},{"key":"2022101808245898900_ciac531-B14","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1111\/j.1468-1331.2007.01868.x","article-title":"Anthrax meningoencephalitis successfully treated","volume":"14","author":"Bindu","year":"2007","journal-title":"Eur J Neurol"},{"key":"2022101808245898900_ciac531-B15","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3201\/eid2009.131481","article-title":"Confirmed Bacillus anthracis infection among persons who inject drugs, Scotland, 2009-2010","volume":"20","author":"Booth","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"2022101808245898900_ciac531-B16","author":"US Food and Drug Administration"},{"key":"2022101808245898900_ciac531-B17","author":"US Food and Drug Administration"},{"key":"2022101808245898900_ciac531-B18","author":"US Food and Drug Administration"},{"key":"2022101808245898900_ciac531-B19","doi-asserted-by":"crossref","first-page":"S432","DOI":"10.1093\/cid\/ciac532","article-title":"Antitoxin use in the prevention and treatment of anthrax disease: a systematic review","volume":"75","author":"Hesse","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2022101808245898900_ciac531-B20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jim.2011.12.002","article-title":"Validation and long term performance characteristics of a quantitative enzyme linked immunosorbent assay (ELISA) for human anti-PA IgG","volume":"376","author":"Semenova","year":"2012","journal-title":"J Immunol Methods"},{"key":"2022101808245898900_ciac531-B21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jim.2008.01.007","article-title":"Standardized, mathematical model-based and validated in vitro analysis of anthrax lethal toxin neutralization","volume":"333","author":"Li","year":"2008","journal-title":"J Immunol Methods"},{"key":"2022101808245898900_ciac531-B22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-144-4-200602210-00009","article-title":"Systematic review: a century of inhalational anthrax cases from 1900 to 2005","volume":"144","author":"Holty","year":"2006","journal-title":"Ann Intern Med"},{"key":"2022101808245898900_ciac531-B23","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3201\/eid0810.020353","article-title":"Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings","volume":"8","author":"Jernigan","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"2022101808245898900_ciac531-B24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1212\/WNL.59.3.327","article-title":"Anthrax meningoencephalitis","volume":"59","author":"Lanska","year":"2002","journal-title":"Neurology"},{"key":"2022101808245898900_ciac531-B25","first-page":"317","article-title":"Anthrax lethal and edema toxins in anthrax pathogenesis","volume":"22","author":"Liu","year":"2014","journal-title":"TrendsMicrobiol"},{"key":"2022101808245898900_ciac531-B26","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1093\/infdis\/jir543","article-title":"Lethal factor toxemia and anti-protective antigen antibody activity in naturally acquired cutaneous anthrax","volume":"204","author":"Boyer","year":"2011","journal-title":"J Infect Dis"},{"key":"2022101808245898900_ciac531-B27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3201\/eid2301.160608","article-title":"Analysis of anthrax immune globulin intravenous with antimicrobial treatment in injection drug users, Scotland, 2009-2010","volume":"23","author":"Cui","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"2022101808245898900_ciac531-B28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3201\/eid2002.130245","article-title":"Lethal factor and anti-protective antigen IgG levels associated with inhalation anthrax, minnesota, USA","volume":"20","author":"Sprenkle","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"2022101808245898900_ciac531-B29","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1086\/512372","article-title":"A case of naturally acquired inhalation anthrax: clinical care and analyses of anti-protective antigen immunoglobulin G and lethal factor","volume":"44","author":"Walsh","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2022101808245898900_ciac531-B30","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1007\/s00216-015-8509-5","article-title":"High-sensitivity MALDI-TOF MS quantification of anthrax lethal toxin for diagnostics and evaluation of medical countermeasures","volume":"407","author":"Boyer","year":"2015","journal-title":"Anal Bioanal Chem"},{"key":"2022101808245898900_ciac531-B31","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/s00216-019-01730-4","article-title":"Zeptomole per milliliter detection and quantification of edema factor in plasma by LC-MS\/MS yields insights into toxemia and the progression of inhalation anthrax","volume":"411","author":"Lins","year":"2019","journal-title":"Anal Bioanal Chem"},{"key":"2022101808245898900_ciac531-B32","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1055\/s-0032-1328882","article-title":"Antimicrobial drug-induced thrombocytopenia: a review of the literature","volume":"38","author":"Loo","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"2022101808245898900_ciac531-B33","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1086\/338403","article-title":"Thrombocytopenia associated with linezolid therapy","volume":"34","author":"Attassi","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2022101808245898900_ciac531-B34","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ijantimicag.2006.04.017","article-title":"High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency","volume":"28","author":"Lin","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"2022101808245898900_ciac531-B35","first-page":"957","article-title":"Is high-dose \u03b2-lactam therapy associated with excessive drug toxicity in critically ill patients?","volume":"82","author":"McDonald","year":"2016","journal-title":"Minerva Anestesiol"},{"key":"2022101808245898900_ciac531-B36","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/clinids\/4.6.1133","article-title":"Clindamycin: a review of fifteen years of experience","volume":"4","author":"Dhawan","year":"1982","journal-title":"Rev Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/Supplement_3\/S364\/46549037\/ciac531.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/75\/Supplement_3\/S364\/46549037\/ciac531.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T08:26:41Z","timestamp":1666081601000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/75\/Supplement_3\/S364\/6762178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,15]]},"references-count":36,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2022,10,17]]},"published-print":{"date-parts":[[2022,10,17]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciac531","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,10,15]]},"published":{"date-parts":[[2022,10,15]]}}}